Boyds is a dynamic and fast-growing global drug development consultancy focused on providing specialist consultancy services to an international client base, supporting the development of new, cutting-edge medicines for patient benefit.
Working with early-stage biotechs, medical device companies and universities, the team supports the development of gene and cell therapies, small molecules and biologics across a wide range of therapeutic areas.
The team has expertise in programme management and product development, clinical operations, medical monitoring, regulatory affairs and strategy, medical writing and provides scientific and medical advice to help translate ideas into medicines.
The company was founded in 2005 by Professor Alan Boyd and now has offices in Cambridge, Crewe, Dublin and Pennsylvania. In 2018, Boyds was awarded the prestigious Queen’s Award for Enterprise, International Trade in recognition for its international work, and in particular its support in the development of gene therapies for the treatment of rare diseases.